A2A-O-03

N/A

Report date: 2025/03/25 16:00:23
NME

Base Information

Drug NameA2A-O-03
Drug Alias NameA2A_O-03A2A-O-03A2A-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGTPase KRas degraders
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesA2A Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesA2A Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A